A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome

Antioxidant therapy in COVID-19: The crucial role of early treatment and antioxidant typology

(2021) Domenico Lapenna   CLINICAL INFECTIOUS DISEASES

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

(2020) Xiaobo Yang et al.   Lancet Respiratory Medicine

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

(2020) Yajing Fu et al.   VIROLOGICA SINICA

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

(2020) Chuan Qin et al.   CLINICAL INFECTIOUS DISEASES

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

(2020) Chi Zhang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Neurological manifestations and complications of COVID-19: A literature review

(2020) Imran Ahmad et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

(2020) Alfonso J. Rodriguez-Morales et al.   Travel Medicine and Infectious Disease

Rationale for the use of N -acetylcysteine in both prevention and adjuvant therapy of COVID-19

(2020) Silvio De Flora et al.   FASEB JOURNAL

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

(2020) Qing Ye et al.   JOURNAL OF INFECTION

Immune Response, Inflammation, and the Clinical Spectrum of COVID-19

(2020) Luis F. García   Frontiers in Immunology

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine

(2020) Homam Ibrahim et al.   CLINICAL IMMUNOLOGY

Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial

(2020) Daryoush Hamidi Alamdari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies

(2020) Arun Samidurai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19

(2020) Yan Liu et al.   MEDICINE

Tackle the free radicals damage in COVID-19

(2020) Jun Wu   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review

(2020) Vincenzo Lariccia et al.   Journal of Clinical Medicine

Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: A meta-analysis

(2017) Ying Zhang et al.   Experimental and Therapeutic Medicine

The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells

(2017) Michael Poppe et al.   PLoS Pathogens

N-Acetylcysteine’s Role in Sepsis and Potential Benefit in Patients With Microcirculatory Derangements

(2017) Jason Chertoff   JOURNAL OF INTENSIVE CARE MEDICINE

The role of oxidative stress during inflammatory processes

(2013) Jérôme Lugrin et al.   BIOLOGICAL CHEMISTRY

Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine

(2012) Manuel Mata et al.   PLoS One

N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)

(2011) Manuel Mata et al.   BIOCHEMICAL PHARMACOLOGY

N-acetylcysteine Protects Striated Muscle in a Model of Compartment Syndrome

(2010) Stephen R. Kearns et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus

(2009) Janina Geiler et al.   BIOCHEMICAL PHARMACOLOGY

The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine

(2008) Mandana Moradi et al.   RESPIRATORY MEDICINE